Valuation dashboard for Retractable Technologies, Inc. (RVP) with P/E N/A, P/B 0.28, EV/EBITDA 4.20 and dividend yield 0.00%. DCF, Graham Number and Earnings Power Value models plus sector comparison against other Healthcare companies.
Retractable Technologies, Inc. is a medical device company focused on the innovation, production, and sale of secure medical instruments, predominantly syringes, for the healthcare sector. Their reach extends across the United States, the broader North and South American continents, and other international territories.
Analysis Summary
Retractable Technologies, Inc. reported revenue of $38.3M in the most recent fiscal year, growing at a 5-year CAGR of -14.1%.
Trailing-twelve-month margins: gross margin 1.1%, operating margin -66.9%, net margin -9.9%.
At the current price of $0.68, RVP has negative trailing earnings (P/E not meaningful) and an ROE of -4.59%. Market capitalisation stands at $20M.
Balance sheet quality for RVP: current ratio of 6.6. A debt-to-equity below 1.0 typically signals conservative capital structure, while a current ratio above 1.5 indicates comfortable short-term liquidity.
Valuation Ratios
| Price / Book | 0.28 |
| EV / EBITDA | 4.20 |
| Dividend Yield | 0.00% |
Valuation Models
| DCF Fair Value | $0.74 |
| vs Current Price | +8.8% |
Peer Comparison
| Symbol | Company | Market Cap | P/E | P/B | ROE |
|---|---|---|---|---|---|
| RVP | Retractable Technologies, Inc. | $20M | 0.28 | -4.6% | |
| 0R29.L | Intuitive Surgical, Inc. | $135.9B | 74.05 | 11.86 | 17.8% |
| ISRG | Intuitive Surgical, Inc. | $135.1B | 44.13 | 7.62 | 17.8% |
| 0R19.L | Becton, Dickinson and Company | $52.5B | 33.21 | 2.19 | 6.6% |
| BDX | Becton, Dickinson and Company | $49.0B | 54.89 | 2.05 | 3.8% |
| RMD | ResMed Inc. | $33.1B | 22.81 | 5.23 | 23.9% |
| 0KW4.L | ResMed Inc. | $31.1B | |||
| MDLN | Medline Inc. | $27.6B | 38.36 | 2.44 | 10.8% |
Price
| Price | $0.68 |
| Market Cap | $20M |
| Exchange | AMEX |
| Country | US |
Profitability
| Return on Equity | -4.59% |
| Return on Invested Capital | -17.62% |
| Return on Assets | -2.38% |
| Gross Margin | 1.10% |
| Operating Margin | -66.90% |
| Net Margin | -9.94% |
Related companies: CLGN · FEMY · HBIO · NRSN · NRXS · NXGL · NXL
Explore sector: Healthcare · Medical - Instruments & Supplies
More sections of RVP: Overview · Financials · Statistics · Estimates · Technical · Ownership · News · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks